The scientist’s investigation covers issues in Thyroid cancer, Internal medicine, Thyroid, Thyroid carcinoma and Endocrinology. The concepts of his Thyroid cancer study are interwoven with issues in Surgery, Survival analysis and Carcinoma. His Internal medicine research includes elements of Gastroenterology and Oncology.
His Thyroid research is multidisciplinary, incorporating perspectives in Hormone and Nuclear medicine. His studies in Endocrinology integrate themes in fields like Heart disease and Dilated cardiomyopathy. His research integrates issues of Fine-needle aspiration, Biopsy, Radiology and General surgery in his study of Thyroid nodules.
Internal medicine, Thyroid cancer, Oncology, Thyroid carcinoma and Thyroid are his primary areas of study. His research is interdisciplinary, bridging the disciplines of Endocrinology and Internal medicine. His Thyroid cancer study combines topics in areas such as Carcinoma, Clinical trial, Pathology and Surgery, Refractory.
His study looks at the relationship between Oncology and topics such as Radioactive iodine, which overlap with Locally advanced. His research in Thyroid carcinoma intersects with topics in Medullary cavity and Cancer research. Steven I. Sherman has included themes like Hormone, Nuclear medicine and General surgery in his Thyroid study.
Steven I. Sherman mainly focuses on Internal medicine, Thyroid cancer, Oncology, Cancer and Cancer research. In his study, Liquid biopsy and Retrospective cohort study is strongly linked to Endocrinology, which falls under the umbrella field of Internal medicine. His Thyroid cancer study is concerned with Thyroid in general.
His Oncology research is multidisciplinary, incorporating elements of Targeted therapy, Anaplastic thyroid cancer, Disease and Refractory. His Cancer study combines topics from a wide range of disciplines, such as Large population and KRAS, Neuroblastoma RAS viral oncogene homolog. His work deals with themes such as Medullary cavity, Radiation therapy and Thyroid nodules, which intersect with Thyroid carcinoma.
His primary scientific interests are in Internal medicine, Cancer, Carcinoma, Thyroid cancer and Endocrinology. As a member of one scientific family, he mostly works in the field of Internal medicine, focusing on Oncology and, on occasion, KRAS and Biomarker. His Cancer research incorporates elements of Surgical oncology, Intensive care medicine, Endocrine surgery and Endocrine system.
His work focuses on many connections between Carcinoma and other disciplines, such as Thyroid carcinoma, that overlap with his field of interest in Thyroid nodules, Adenocarcinoma and Radiation therapy. His Thyroid cancer study results in a more complete grasp of Thyroid. His biological study spans a wide range of topics, including Medullary cavity and Radiology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
David S. Cooper;Gerard M. Doherty;Bryan R. Haugen;Richard T. Kloos.
Thyroid (2009)
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.
Bryan R. Haugen;Erik K. Alexander;Keith C. Bible;Gerard M. Doherty.
Thyroid (2009)
Management guidelines for patients with thyroid nodules and differentiated thyroid cancer.
David S. Cooper;Gerard M. Doherty;Bryan R. Haugen;Richard T. Kloos.
Thyroid (2006)
Integrated Genomic Characterization of Papillary Thyroid Carcinoma
Nishant Agrawal;Rehan Akbani;B. Arman Aksoy;Adrian Ally.
Cell (2014)
Management of thyroid nodules detected at US: Society of radiologists in ultrasound consensus conference statement
Mary C. Frates;Carol B. Benson;J. William Charboneau;Edmund S. Cibas.
Radiology (2005)
Lenvatinib versus placebo in radioiodine-refractory thyroid cancer.
Martin Schlumberger;Makoto Tahara;Lori J. Wirth;Bruce Robinson.
The New England Journal of Medicine (2015)
Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial
Marcia S Brose;Christopher M Nutting;Barbara Jarzab;Rossella Elisei.
The Lancet (2014)
Cabozantinib in Progressive Medullary Thyroid Cancer
Rossella Elisei;Martin J. Schlumberger;Stefan P. Müller;Patrick Schöffski.
Journal of Clinical Oncology (2013)
A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma.
Ernest L. Mazzaferri;R. J. Robbins;C. A. Spencer;L. E. Braverman.
The Journal of Clinical Endocrinology and Metabolism (2003)
A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer.
Bryan R. Haugen;Furio Pacini;Christoph Reiners;Martin Schlumberger.
The Journal of Clinical Endocrinology and Metabolism (1999)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Institut Gustave Roussy
University of Pisa
Medical College of Wisconsin
Royal North Shore Hospital
University of Siena
The University of Texas MD Anderson Cancer Center
The University of Texas MD Anderson Cancer Center
Medical College of Wisconsin
University of Milan
The University of Texas MD Anderson Cancer Center
IBM (United States)
The Open University
ETH Zurich
Iowa State University
Utrecht University
Nanjing University of Science and Technology
University of California, San Diego
State University of Maringa
Florida State University
Peking University
University of Padua
Mayo Clinic
Case Western Reserve University
University of Cincinnati
University of York
Tampere University